Head-to-head · Value Score
Trimi Health vs EdgeRx
Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, EdgeRx a 82. Here's who gives you the honest lower price — and where each one bites back.
Trimi Health
#3 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameEdgeRx
#53 · Grade B+ · Good Value
Est. first month
$229/mo
Save ~83% vs brand-nameThe verdict
Trimi Health takes it on Value Score, 89 to 82 — an est. $99/mo first month, with no teaser step-up baked in. EdgeRx isn't out of it: Men who want a straightforward, disclosed weekly-injectable price on either molecule and value knowing the pharmacy filling the script by name.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Trimi Health | EdgeRx |
|---|---|---|
| Value Score | 89 (A) | 82 (B+) |
| Est. first month | $99/mo | $229/mo |
| Save vs brand-name | ~93% | ~83% |
| Semaglutide | $99/mo | $229/mo injectable |
| Tirzepatide | $125/mo | $299/mo injectable |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Trimi Health
The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.
Why it's a deal
- Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
- Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
- Nationwide 50-state reach, so the low price isn't gated to a handful of states
The fine print
- Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
- Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
- Newer brand with a thin public track record
EdgeRx
A men's-only protocol shop with flat, disclosed GLP-1 pricing, a named Chief Medical Advisor, and a named 503A compounding pharmacy — rare transparency for this tier of the board.
Why it's a deal
- Both molecules disclosed up front — semaglutide $229/mo, tirzepatide $299/mo, both once-weekly injectable with free shipping and no separate physician fee
- Named compounding pharmacy — Strive Pharmacy, 503A, operating since 2018 — most peers name none
- Named Chief Medical Advisor, Dr. John Starke, MD (ABEM board-certified)
- LegitScript certified
The fine print
- Men-only — not built for, or marketed to, women or other readers
- The named Chief Medical Advisor does not personally prescribe; the actual prescribing pool is unnamed licensed physicians
- Third-party lab testing is claimed but no specific lab is named
- Excludes Arkansas, Indiana, Minnesota, and South Carolina
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Trimi Health is ranked on the Trimi Health alternatives board, and the same list for the other side is on alternatives to EdgeRx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.